{"id":45114,"date":"2022-06-15T16:01:27","date_gmt":"2022-06-15T14:01:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-10-8-bn-self-injection-devices-market-trends-analysis-2022-2030-by-product-autoinjectors-needle-free-injectors-usability-disposable-reusable-application-cancer-pain-management-res\/"},"modified":"2022-06-15T16:01:27","modified_gmt":"2022-06-15T14:01:27","slug":"global-10-8-bn-self-injection-devices-market-trends-analysis-2022-2030-by-product-autoinjectors-needle-free-injectors-usability-disposable-reusable-application-cancer-pain-management-res","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-10-8-bn-self-injection-devices-market-trends-analysis-2022-2030-by-product-autoinjectors-needle-free-injectors-usability-disposable-reusable-application-cancer-pain-management-res\/","title":{"rendered":"Global $10.8 Bn Self-injection Devices Market Trends\/Analysis 2022-2030 by Product (Autoinjectors, Needle-free Injectors), Usability (Disposable, Reusable), Application (Cancer, Pain Management) – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Self-injection Devices Market Size, Share & Trends Analysis Report by Product (Autoinjectors, Needle-free Injectors), by Usability (Disposable, Reusable), by Application (Cancer, Pain Management), by Region, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global self-injection devices market size is expected to reach USD 10.8 billion by 2030 and is projected to expand at a CAGR of 5.7% from 2022 to 2030\n<\/p>\n

\nIncreasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.\n<\/p>\n

\nPrevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices.\n<\/p>\n

\nSeveral auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.\n<\/p>\n

\nInnovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients.\n<\/p>\n

\nThe majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.\n<\/p>\n

\nThe COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design.\n<\/p>\n

\nSignificantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices.\n<\/p>\n

\nPost-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.\n<\/p>\n

\nSelf-injection Devices Market Report Highlights<\/strong>\n<\/p>\n